Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Research Summary
hospital hallway
Research Summary
Phase 3 Trial Shows Mim8 Prophylaxis Reduces Bleeding in Patients With Hemophilia A
05/08/2026
Anthony Calabro, MA
A phase 3 randomized trial found that Mim8 prophylaxis significantly reduced bleeding rates compared with on-demand therapy and clotting factor prophylaxis in patients with hemophilia A with or without...
05/08/2026
Research Summary
Blood cells, 3D illustration
Research Summary
Marstacimab Reduces Bleeding Rates in Adolescent, Adult Men With Hemophilia A/B With Inhibitors
05/01/2026
Ashton L. Stahl
A phase 3 trial evaluated weekly marstacimab prophylaxis in adolescents and adults with hemophilia A or B with inhibitors.
05/01/2026
Research Summary
physician looking at data
Research Summary
5-Year HOPE-B Data Support Durable Hemophilia B Gene Therapy
05/01/2026
Ashton L. Stahl
Final phase 3 results assessed 5-year efficacy and safety of etranacogene dezaparvovec in adults with hemophilia B.
05/01/2026